blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3086784

EP3086784 - BICALUTAMIDE ANALOGS OR (S)-BICALUTAMIDE AS EXOCYTOSIS ACTIVATING COMPOUNDS FOR USE IN THE TREATMENT OF A LYSOSOMAL STORAGE DISORDER OR GLYCOGENOSIS [Right-click to bookmark this link]
Former [2016/44]BICALUTAMIDE ANALOGS OR (S)-BI CALUTAM IDE AS EXOCYTOSIS ACTIVATING COMPOUNDS FOR USE IN THE TREATMENT OF A LYSOSOMAL STORAGE DISORDER OR GLYCOGENOSIS
[2018/34]
StatusNo opposition filed within time limit
Status updated on  07.02.2020
Database last updated on 28.06.2024
FormerThe patent has been granted
Status updated on  22.02.2019
FormerGrant of patent is intended
Status updated on  18.02.2019
FormerExamination is in progress
Status updated on  28.01.2019
FormerGrant of patent is intended
Status updated on  08.10.2018
FormerExamination is in progress
Status updated on  28.07.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK
published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
BCN Peptides, S.A.
Polígono Industrial Els Vinyets-Els Fogars
Ctra. Comarcal 244, km 22
08777 Sant Quintí de Mediona / ES
[2016/44]
Inventor(s)01 / FARRERA-SINFREU, Josep
Cap de la Vila 3
E-25595 Tírvia / ES
02 / MATALONGA BORREL, Leslie
Ferran Puig 82 ático 3ª
E-08023 Barcelona / ES
03 / GORT MAS, Laura
Av. Osona 24
E-08550 Balenyà / ES
04 / PASCUAL MARTÍNEZ, Roberto
Primavera 18 2º D
E-03012 Alicante / ES
05 / FERRER MONTIEL, Antonio
Periodista Asunción Valdés 3 Bloque Y 2ºN
E-03540 Alicante / ES
06 / RIBES RUBIÓ, Antonia
Alexandre Soler i March 1
E-08950 Esplugues de Llobregat / ES
07 / PONSATI OBIOLS, Berta
Alaba 50 3º 2ª
E-08005 Barcelona / ES
 [2019/10]
Former [2016/44]01 / FARRERA-SINFREU, Josep
Cap de la Vila 3
E-25595 Tírvia / ES
02 / MATALONGA BORREL, Leslie
Ferran Puig 82 ático 3ª
E-08023 Barcelona / ES
03 / GORT MAS, Laura
Serreta 34
E-08550 Balenyà / ES
04 / PASCUAL MARTÍNEZ, Roberto
Primavera 18 2º D
E-03012 Alicante / ES
05 / FERRER MONTIEL, Antonio
Periodista Asunción Valdés 3 Bloque Y 2ºN
E-03540 Alicante / ES
06 / RIBES RUBIÓ, Antonia
Alexandre Soler i March 1
E-08950 Esplugues de Llobregat / ES
07 / PONSATI OBIOLS, Berta
Alaba 50 3º 2ª
E-08005 Barcelona / ES
Representative(s)Carvajal y Urquijo, Isabel, et al
Clarke, Modet & Co.
Suero de Quiñones, 34-36
28002 Madrid / ES
[2016/44]
Application number, filing date14815747.219.12.2014
[2016/44]
WO2014EP78745
Priority number, dateEP2013038254123.12.2013         Original published format: EP 13382541
[2016/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015097088
Date:02.07.2015
Language:EN
[2015/26]
Type: A1 Application with search report 
No.:EP3086784
Date:02.11.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 02.07.2015 takes the place of the publication of the European patent application.
[2016/44]
Type: B1 Patent specification 
No.:EP3086784
Date:27.03.2019
Language:EN
[2019/13]
Type: B9 Corrected patent specification 
No.:EP3086784
Date:16.10.2019
[2019/42]
Search report(s)International search report - published on:EP02.07.2015
ClassificationIPC:A61K31/167, A61P3/00, A61K31/00, G01N33/566, A61K31/277
[2018/34]
CPC:
A61K31/167 (EP,KR,RU,US); A61K31/277 (RU,US); A61K31/07 (KR);
A61K31/355 (KR); A61K31/375 (KR); A61K31/445 (KR);
A61K47/42 (RU,US); A61K9/16 (KR); A61K9/51 (KR);
A61P3/00 (EP); C07C317/32 (RU); C07C323/41 (RU);
C07C331/28 (RU); G01N33/566 (US); G01N2333/70596 (US);
G01N2800/7066 (US) (-)
Former IPC [2016/44]A61K31/00, A61K31/167
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/44]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:BICALUTAMID-ANALOGA ODER (S)-BICALUTAMID ALS EXOZYTOSE-AKTIVIERENDE VERBINDUNGEN ZUR VERWENDUNG IN DER BEHANDLUNG EINER LYSOSOMALEN SPEICHERKRANKHEIT ODER GLYCOGENOSE[2018/34]
English:BICALUTAMIDE ANALOGS OR (S)-BICALUTAMIDE AS EXOCYTOSIS ACTIVATING COMPOUNDS FOR USE IN THE TREATMENT OF A LYSOSOMAL STORAGE DISORDER OR GLYCOGENOSIS[2018/34]
French:ANALOGUES DE BICALUTAMIDE OU (S)-BICALUTAMIDE COMME COMPOSÉS ACTIVANT L'EXOCYTOSE POUR L'UTILISATION DANS LE TRAITEMENT D'UN TROUBLE DE SURCHARGE LYSOSOMALE OU UNE GLYCOGÉNOSE[2018/34]
Former [2016/44]BICALUTAMID-ANALOGA ODER (S)-BI-CALUTAMID ALS EXOZYTOSE-AKTIVIERENDE VERBINDUNGEN ZUR VERWENDUNG BEI DER BEHANDLUNG VON LYSOSOMALEN SPEICHERKRANKHEITEN ODER GLYKOGENOSE
Former [2016/44]BICALUTAMIDE ANALOGS OR (S)-BI CALUTAM IDE AS EXOCYTOSIS ACTIVATING COMPOUNDS FOR USE IN THE TREATMENT OF A LYSOSOMAL STORAGE DISORDER OR GLYCOGENOSIS
Former [2016/44]ANALOGUES DU BICALUTAMIDE OU (S)-BICALUTAMIDE EN TANT QUE COMPOSÉS ACTIVANT L'EXOCYTOSE POUR LEUR UTILISATION DANS LE TRAITEMENT D'UN TROUBLE DE SURCHARGE LYSOSOMALE OU DE LA GLYCOGENÈSE
Entry into regional phase10.06.2016National basic fee paid 
10.06.2016Designation fee(s) paid 
10.06.2016Examination fee paid 
Examination procedure10.06.2016Amendment by applicant (claims and/or description)
10.06.2016Examination requested  [2016/44]
26.07.2017Despatch of a communication from the examining division (Time limit: M06)
30.01.2018Reply to a communication from the examining division
09.10.2018Communication of intention to grant the patent
25.01.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
25.01.2019Fee for grant paid
25.01.2019Fee for publishing/printing paid
18.02.2019Information about intention to grant a patent
18.02.2019Receipt of the translation of the claim(s)
Opposition(s)03.01.2020No opposition filed within time limit [2020/11]
Fees paidRenewal fee
27.12.2016Renewal fee patent year 03
27.12.2017Renewal fee patent year 04
31.12.2018Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL27.03.2019
CY27.03.2019
HR27.03.2019
MC27.03.2019
MK27.03.2019
RS27.03.2019
SI27.03.2019
SM27.03.2019
TR27.03.2019
IS27.07.2019
LU19.12.2019
[2022/31]
Former [2021/26]AL27.03.2019
CY27.03.2019
HR27.03.2019
MC27.03.2019
RS27.03.2019
SI27.03.2019
SM27.03.2019
TR27.03.2019
IS27.07.2019
LU19.12.2019
Former [2020/46]AL27.03.2019
HR27.03.2019
MC27.03.2019
RS27.03.2019
SI27.03.2019
SM27.03.2019
TR27.03.2019
IS27.07.2019
LU19.12.2019
Former [2020/39]AL27.03.2019
HR27.03.2019
MC27.03.2019
RS27.03.2019
SI27.03.2019
SM27.03.2019
TR27.03.2019
IS27.07.2019
Former [2020/17]AL27.03.2019
HR27.03.2019
RS27.03.2019
SI27.03.2019
SM27.03.2019
TR27.03.2019
IS27.07.2019
Former [2020/13]AL27.03.2019
HR27.03.2019
RS27.03.2019
SI27.03.2019
SM27.03.2019
IS27.07.2019
Former [2020/04]AL27.03.2019
HR27.03.2019
RS27.03.2019
SM27.03.2019
IS27.07.2019
Former [2019/52]AL27.03.2019
HR27.03.2019
RS27.03.2019
SM27.03.2019
Former [2019/50]AL27.03.2019
HR27.03.2019
RS27.03.2019
Former [2019/39]HR27.03.2019
RS27.03.2019
Cited inInternational search[XY]WO2008008433  (UNIV TENNESSEE RES FOUNDATION [US], et al);
 [Y]WO2011109448  (BAYLOR RES INST [US], et al);
by applicantWO2010015816
 WO2011109448
 US2013023488
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.